Blood eosinophils in COPD: are biologics for everyone?

Ther Adv Respir Dis. 2026 Jan-Dec;20:17534666261471839. doi: 10.1177/17534666261471839. Epub 2026 Sep 19.ABSTRACTBACKGROUND: Type 2 (T2) biologics represent a promising treatment option for chronic obstructive pulmonary disease (COPD) patients with eosinophilic inflammation.OBJECTIVES: To evaluate t

M Marco Vanetti

Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage

Eur J Neurol. 2026 Sep;33(9):e70762. doi: 10.1111/ene.70762.ABSTRACTBACKGROUND: The timing of ischemic stroke and intracerebral hemorrhage (ICH) onsets follow distinct daily patterns, but it remains unclear whether these patterns influence ICH outcomes.METHODS: Consecutive data were obtained from th

F Franziska Lieschke